These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 32737925)
1. Improved detection methods significantly increase the detection window for EPO microdoses. Martin L; Martin JA; Collot D; Hoang O; Audran M; Ericsson M; Marchand A Drug Test Anal; 2021 Jan; 13(1):101-112. PubMed ID: 32737925 [TBL] [Abstract][Full Text] [Related]
2. Detection of recombinant EPO in blood and urine samples with EPO WGA MAIIA, IEF and SAR-PAGE after microdose injections. Dehnes Y; Shalina A; Myrvold L Drug Test Anal; 2013; 5(11-12):861-9. PubMed ID: 24190107 [TBL] [Abstract][Full Text] [Related]
3. Doping control of biosimilar epoetin kappa and other recombinant erythropoietins after intravenous application. Okano M; Sato M; Kaneko E; Kageyama S Drug Test Anal; 2011; 3(11-12):798-805. PubMed ID: 22012825 [TBL] [Abstract][Full Text] [Related]
4. Data from a microdosed recombinant human erythropoietin administration study applying the new biotinylated clone AE7A5 antibody and a further optimized sarcosyl polyacrylamide gel electrophoresis protocol. Reichel C; Erceg D; Lorenc B; Scheiblhofer V; Farmer L; Zanitzer K; Geisendorfer T; Gmeiner G; Thevis M Drug Test Anal; 2023 Feb; 15(2):163-172. PubMed ID: 33450134 [TBL] [Abstract][Full Text] [Related]
5. Fc-fragment removal allows the EPO-Fc fusion protein to be detected in blood samples by IEF-PAGE. Postnikov P; Krotov G; Mesonzhnik N; Efimova Y; Rodchenkov G Drug Test Anal; 2015; 7(11-12):999-1008. PubMed ID: 26695487 [TBL] [Abstract][Full Text] [Related]
6. New insights for identification of doping with recombinant human erythropoietin micro-doses after high hydration. Martin L; Ashenden M; Bejder J; Hoffmann M; Nordsborg N; Karstoft K; Morkeberg J; Sharpe K; Lasne F; Marchand A Drug Test Anal; 2016 Nov; 8(11-12):1119-1130. PubMed ID: 27390252 [TBL] [Abstract][Full Text] [Related]
7. Combined administration of microdoses of growth hormone and erythropoietin: Effects on performance and evaluation of GH detection capability using anti-doping methods. Marchand A; Martin JA; Collot D; Hoang O; Roulland I; Semence F; Sottas PE; Audran M; Varlet-Marie E Drug Test Anal; 2019 Nov; 11(11-12):1698-1713. PubMed ID: 31301268 [TBL] [Abstract][Full Text] [Related]
8. Sensitivity and specificity of detection methods for erythropoietin doping in cyclists. Heuberger JAAC; van Eenoo P; Rotmans JI; Gal P; Stuurman FE; Post TE; Daniels JMA; Ram H; de Hon O; Burggraaf J; Cohen AF Drug Test Anal; 2019 Sep; 11(9):1290-1301. PubMed ID: 31232530 [TBL] [Abstract][Full Text] [Related]
9. SDS-PAGE of recombinant and endogenous erythropoietins: benefits and limitations of the method for application in doping control. Reichel C; Kulovics R; Jordan V; Watzinger M; Geisendorfer T Drug Test Anal; 2009 Jan; 1(1):43-50. PubMed ID: 20355158 [TBL] [Abstract][Full Text] [Related]
10. Evaluation of AMGEN clone 9G8A anti-Epo antibody for application in doping control. Reichel C; Benetka W; Lorenc B; Thevis M Drug Test Anal; 2016 Nov; 8(11-12):1131-1137. PubMed ID: 27552163 [TBL] [Abstract][Full Text] [Related]
11. Desialylation improves the detection of recombinant erythropoietins in urine samples analyzed by SDS-PAGE. Desharnais P; Naud JF; Ayotte C Drug Test Anal; 2013; 5(11-12):870-6. PubMed ID: 23720238 [TBL] [Abstract][Full Text] [Related]
12. Dried blood spots for erythropoietin analysis: Detection of micro-doses, EPO c.577del variant and comparison with in-competition matching urine samples. Heiland CE; Martin L; Zhou X; Zhang L; Ericsson M; Marchand A Drug Test Anal; 2024 Jun; 16(6):650-654. PubMed ID: 37942506 [TBL] [Abstract][Full Text] [Related]
13. SARCOSYL-PAGE: a new method for the detection of MIRCERA- and EPO-doping in blood. Reichel C; Abzieher F; Geisendorfer T Drug Test Anal; 2009 Nov; 1(11-12):494-504. PubMed ID: 20355164 [TBL] [Abstract][Full Text] [Related]
14. Detection of a nonerythropoietic erythropoietin, Neuro-EPO, in blood after intranasal administration in rat. Martin L; Garcia Rodriguez JC; Audran M; Ericsson M; Maurice T; Marchand A Drug Test Anal; 2020 Nov; 12(11-12):1605-1613. PubMed ID: 32856413 [TBL] [Abstract][Full Text] [Related]
15. An optimized SDS-PAGE protocol with a new blotting system for the initial testing procedure of ESAs in doping control. Martin L; Martin JA; Audran M; Marchand A Drug Test Anal; 2022 Jan; 14(1):181-187. PubMed ID: 33269539 [TBL] [Abstract][Full Text] [Related]
16. Effect of single doses of methoxypolyethylene glycol-epoetin beta (CERA, Mircera™) and epoetin delta (Dynepo™) on isoelectric erythropoietin profiles and haematological parameters. Dehnes Y; Hemmersbach P Drug Test Anal; 2011 May; 3(5):291-9. PubMed ID: 21387570 [TBL] [Abstract][Full Text] [Related]
17. Detection of recombinant erythropoietin biosimilar Jimaixin™ after administration in healthy subjects. Martin L; Kafi R; Zhou X; Zhang L; Ericsson M; Marchand A Drug Test Anal; 2022 Jan; 14(1):72-79. PubMed ID: 34391213 [TBL] [Abstract][Full Text] [Related]
18. Immunomagnetic beads-based isolation of erythropoietins from urine and blood for sports anti-doping control. Desharnais P; Naud JF; Ayotte C Drug Test Anal; 2017 Nov; 9(11-12):1744-1752. PubMed ID: 28994210 [TBL] [Abstract][Full Text] [Related]
19. Detection of EPO-Fc fusion protein in human blood: screening and confirmation protocols for sports drug testing. Reichel C; Thevis M Drug Test Anal; 2012 Nov; 4(11):818-29. PubMed ID: 22764129 [TBL] [Abstract][Full Text] [Related]
20. Progress in the Detection of Erythropoietin in Blood, Urine, and Tissue. Yasuoka Y; Izumi Y; Sands JM; Kawahara K; Nonoguchi H Molecules; 2023 May; 28(11):. PubMed ID: 37298922 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]